Oct 30, 2020 / NTS GMT
Presentation
Oct 30, 2020 / NTS GMT
=====================
Corporate Participants
=====================
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director
* Mike Kitagawa
Astellas Pharma Inc. - Senior VP of Development Project Management
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, CFO & Representative Director
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Yo Mizuno
Tokio Marine Asset
Astellas Pharma Inc
(TSE:4503)
円
2,175.5
-21 (-0.96%)
Market Cap: 3.94 Tn
Enterprise Value: 4.21 Tn
PE Ratio: 13.41
PB Ratio: 2.13
GF Score: 81/100 Q2 2021 Astellas Pharma Inc Earnings Presentation Transcript
Oct 30, 2020 / NTS GMT
Release Date Price:
円1435
(-1.81%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot